2 results match your criteria: "College of Pharmaceutical Sciences Southwest University Chongqing China.[Affiliation]"
Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non-small cell lung cancer.
Cancer Innov
August 2024
Department of Toxicology, School of Public Health Chongqing Medical University Chongqing China.
Background: Non-small cell lung cancer (NSCLC), including the lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD) subtypes, is a malignant tumor type with a poor 5-year survival rate. The identification of new powerful diagnostic biomarkers, prognostic biomarkers, and potential therapeutic targets in NSCLC is urgently required.
Methods: The UCSC Xena, UALCAN, and GEO databases were used to screen and analyze differentially expressed genes, regulatory modes, and genetic/epigenetic alterations in NSCLC.
Article Synopsis
- * Advances in nanotechnology are making it easier to deliver anti-fibrotic drugs to challenging areas in the body, overcoming barriers that previously hindered treatment options.
- * The review highlights that while preclinical studies show promise with various molecular, cellular, and tissue-level targets for intestinal fibrosis, clinical trials for liver fibrosis mainly focus on reducing inflammation and improving metabolic issues, leading to potential new treatment strategies using stem cells and targeted therapies.